Why the study?
Does a physician-pharmacist collaborative intervention increase costs compared to usual care in patients with hypertension?
Does a physician-pharmacist collaborative intervention increase costs compared to usual care in patients with hypertension?
A physician-pharmacist collaborative intervention for hypertension improves blood pressure control but significantly increases the short-term cost of care.
No takes yet. Share an insight, caveat, or question.
Collaborative hypertension care was associated with higher short-term costs; leaves open cost-effectiveness versus usual care in randomized trials.
Kulchaitanaroaj et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: